United States

Back to map

Showing 81-90 of 325 grants

Title Institution Researcher Program Duration Total Award Amount
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-August-2025 $850,000.00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-January-2026 $750,000.00
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273,424.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
Assessing immunotherapeutic potential of a natural IgM antibody for the treatment of T1D Johns Hopkins University Abdel Hamad Cures 01-June-2024 to 31-January-2026 $199,881.88
Curing New-Onset Type 1 Diabetes with a Restorative Antibody Therapy Johns Hopkins University Dax Fu Cures 01-April-2025 to 31-March-2026 $200,000.00
A Novel Bifunctional Biologic for Type 1 Diabetes Johns Hopkins University Giorgio Raimondi Cures 01-February-2025 to 31-January-2028 $995,376.00
Exploring Immunologic Mechanisms of Indirect (Encapsulated) Islet Graft Rejection Johns Hopkins University Joshua Doloff Cures 01-November-2025 to 31-October-2028 $1,125,000.00
REGULATORY ROLE OF CADM1 DURING AUTOIMMUNE DIABETES Johns Hopkins University Matthew Poy Cures 01-December-2024 to 30-November-2027 $900,000.00
Towards FDA approval of Autonomous AI for diabetic retinopathy screening in youth Johns Hopkins University Risa Wolf Improving Lives 01-January-2023 to 31-December-2025 $637,547.20